Summary:
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, And Tolerability of Serlopitant For The Treatment of Pruritus In Adults With Plaques Psoriasis.
Qualified Participants Must:
• Be 18-80 years old
•
Plaque psoriasis at least 6 months
•
BSA less than or equal to 10%
•
Pruritis at least 4 weeks
Qualified Participants May Receive:
14 weeks of treatment
Oral IP vs placebo 1:1